Spectral Diagnostics EPS - Earnings per Share 2010-2025 | EDTXF
Spectral Diagnostics eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Spectral Diagnostics Annual EPS | |
|---|---|
| 2024 | $-0.04 |
| 2023 | $-0.04 |
| 2022 | $-0.03 |
| 2021 | $-0.02 |
| 2020 | $-0.03 |
| 2019 | $-0.02 |
| 2018 | $-0.01 |
| 2017 | $-0.02 |
| 2016 | $-0.04 |
| 2015 | $-0.04 |
| 2014 | $-0.05 |
| 2013 | $-0.08 |
| 2012 | $-0.08 |
| 2011 | $-0.07 |
| 2010 | $-0.10 |
| 2009 | $0.00 |
| Spectral Diagnostics Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.03 |
| 2024-12-31 | $0.00 |
| 2024-09-30 | $-0.03 |
| 2024-06-30 | $0.00 |
| 2024-03-31 | $-0.01 |
| 2023-12-31 | $-0.02 |
| 2023-09-30 | $-0.01 |
| 2023-06-30 | $-0.01 |
| 2023-03-31 | $-0.01 |
| 2022-12-31 | $-0.01 |
| 2022-09-30 | $-0.01 |
| 2022-06-30 | $-0.01 |
| 2022-03-31 | $-0.01 |
| 2021-12-31 | $0.00 |
| 2021-09-30 | $-0.01 |
| 2021-06-30 | $-0.01 |
| 2021-03-31 | $-0.01 |
| 2020-12-31 | $-0.01 |
| 2020-09-30 | $-0.01 |
| 2020-06-30 | $-0.01 |
| 2020-03-31 | $-0.01 |
| 2019-12-31 | $0.00 |
| 2019-09-30 | $-0.01 |
| 2019-06-30 | $0.00 |
| 2019-03-31 | $0.00 |
| 2018-12-31 | $0.00 |
| 2018-09-30 | $0.00 |
| 2018-06-30 | $-0.01 |
| 2018-03-31 | $0.00 |
| 2017-12-31 | $-0.01 |
| 2017-09-30 | $0.00 |
| 2017-06-30 | $0.00 |
| 2017-03-31 | $0.00 |
| 2016-12-31 | $0.00 |
| 2016-09-30 | $-0.01 |
| 2016-06-30 | $-0.02 |
| 2016-03-31 | $-0.02 |
| 2015-12-31 | $-0.02 |
| 2015-09-30 | $-0.01 |
| 2015-06-30 | $-0.01 |
| 2015-03-31 | $-0.01 |
| 2014-12-31 | $0.00 |
| 2014-09-30 | $-0.01 |
| 2014-06-30 | $-0.02 |
| 2014-03-31 | $-0.02 |
| 2013-12-31 | $-0.03 |
| 2013-09-30 | $-0.02 |
| 2013-06-30 | $-0.02 |
| 2013-03-31 | $-0.02 |
| 2012-12-31 | $-0.02 |
| 2012-09-30 | $-0.02 |
| 2012-06-30 | $-0.02 |
| 2012-03-31 | $-0.02 |
| 2011-12-31 | $-0.01 |
| 2011-09-30 | $-0.02 |
| 2011-06-30 | $-0.02 |
| 2011-03-31 | $-0.02 |
| 2010-12-31 | $-0.03 |
| 2010-09-30 | $-0.02 |
| 2010-06-30 | $-0.02 |
| 2010-03-31 | $-0.05 |
| 2009-12-31 | $0.00 |
| 2009-09-30 | $0.00 |
| 2009-06-30 | $0.00 |
| 2009-03-31 | $-0.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.309B | $0.002B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.057B | 22.51 |
| Intuitive Surgical (ISRG) | United States | $169.665B | 70.33 |
| IDEXX Laboratories (IDXX) | United States | $51.770B | 53.88 |
| Edwards Lifesciences (EW) | United States | $47.755B | 31.65 |
| Alcon (ALC) | Switzerland | $39.366B | 26.43 |
| IQVIA Holdings (IQV) | United States | $32.438B | 18.33 |
| DexCom (DXCM) | United States | $29.545B | 44.32 |
| Mettler-Toledo (MTD) | United States | $26.800B | 31.81 |
| STERIS (STE) | Ireland | $24.136B | 25.69 |
| Waters (WAT) | United States | $17.964B | 24.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
| Hologic (HOLX) | United States | $14.929B | 16.17 |
| Penumbra (PEN) | United States | $10.633B | 77.68 |
| Globus Medical (GMED) | United States | $8.275B | 19.09 |
| Sysmex ADR (SSMXY) | Japan | $7.913B | 25.14 |
| Masimo (MASI) | United States | $7.590B | 25.54 |
| Teleflex (TFX) | United States | $5.586B | 9.02 |
| Glaukos (GKOS) | United States | $5.495B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.56 |
| Integer Holdings (ITGR) | United States | $3.779B | 18.86 |
| LivaNova (LIVN) | United Kingdom | $3.078B | 17.62 |
| Veracyte (VCYT) | United States | $2.387B | 32.98 |
| Alphatec Holdings (ATEC) | United States | $2.353B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.235B | 0.00 |
| Artivion (AORT) | United States | $2.073B | 104.60 |
| Nihon Kohden (NHNKY) | Japan | $1.992B | 23.78 |
| Elekta AB (EKTAY) | Sweden | $1.815B | 17.59 |
| Integra LifeSciences Holdings (IART) | United States | $1.179B | 6.75 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.046B | 0.00 |
| IRadimed (IRMD) | United States | $0.921B | 44.72 |
| Tandem Diabetes Care (TNDM) | United States | $0.845B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.819B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.719B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.554B | 9.79 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.439B | 3.52 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.385B | 91.83 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.48 |
| RxSight (RXST) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.303B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 20.48 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.236B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| CVRx (CVRX) | United States | $0.205B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.107B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.60 |